Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Dec 9;10(6):272-6.
doi: 10.1007/BF02219667.

The influence of ofloxacin and enoxacin on the metabolic pathways of theophylline in healthy volunteers. A pilot study

Affiliations

The influence of ofloxacin and enoxacin on the metabolic pathways of theophylline in healthy volunteers. A pilot study

W J Wijnands et al. Pharm Weekbl Sci. .

Abstract

The pharmacokinetic parameters of theophylline and its major metabolites were measured in two healthy volunteers, after the administration of theophylline alone and during co-medication with ofloxacin, 200 mg twice daily, or enoxacin, 200 mg twice daily. During enoxacin co-medication, elimination half-lives of theophylline increased from 8.7 h to 17.4 h and from 6.1 to 12.3 h, respectively. As the renal clearance of theophylline did not change, the decreased elimination of theophylline during enoxacin co-medication must result from a reduced metabolic clearance. Enoxacin co-medication caused a clearly decreased formation of the metabolites 1-methyluric acid and 3-methylxanthine, formed by N-demethylation, whereas the C-8 oxidation of theophylline was less influenced compared to the blank. Enoxacin's interference with the theophylline disposition is predominantly based on the inhibition of the microsomal N-demethylation. Ofloxacin co-medication did not induce a change in the plasma parameters or renal excretion of theophylline and its metabolites.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Antimicrob Chemother. 1984 Sep;14 Suppl C:83-9 - PubMed
    1. Lancet. 1984 Jul 14;2(8394):108-9 - PubMed
    1. Clin Pharmacol Ther. 1979 Nov;26(5):660-7 - PubMed
    1. Clin Pharmacol Ther. 1982 Mar;31(3):358-69 - PubMed
    1. Clin Pharmacol Ther. 1981 Feb;29(2):224-9 - PubMed

LinkOut - more resources